Clinical Significance of Trochlear Calcifications in the Orbit

REFERENCES

1. 1.↵
   1. Hart BL,
   2. Spar JA,
   3. Orrison WW Jr.

   . Calcification of the trochlear apparatus of the orbit: CT appearance and association with diabetes and age. AJR Am J Roentgenol 1992;159:1291–94

   CrossRefPubMed
2. 2.↵
   1. Ko S,
   2. Kim Y

   . Incidence of calcification of the trochlear apparatus in the orbit. Korean J Ophthalmol 2010;24:1–3

   CrossRefPubMed
3. 3.↵
   1. Murray JL,
   2. Hayman LA,
   3. Tang RA,
   4. et al

   . Incidental asymptomatic orbital calcifications. J Neuroophthalmol 1995;15:203–08

   CrossRefPubMed
4. 4.↵
   1. Helveston EM,
   2. Merriam WW,
   3. Ellis FD,
   4. et al

   . The trochlea: a study of the anatomy and physiology. Ophthalmology 1982;89:124–33

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Sobel RK,
   2. Goldstein SM

   . Trochlear calcification: a common entity. Orbit 2012;31:94–96

   CrossRefPubMed
6. 6.↵
   1. Froula PD,
   2. Bartley GB,
   3. Garrity JA,
   4. et al

   . The differential diagnosis of orbital calcification as detected on computed tomographic scans. Mayo Clin Proc 1993;68:256–61

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Xiao TL,
   2. Kalariya NM,
   3. Yan ZH,
   4. et al

   . Trochlear calcification and intraorbital foreign body in ocular trauma patients. Chin J Traumatol 2009;12:210–13

   PubMed
8. 8.↵
   1. Shriver EM,
   2. McKeown CA,
   3. Johnson TE

   . Trochlear calcification mimicking an orbital foreign body. Ophthal Plast Reconstr Surg 2011;27:e143–44

   CrossRefPubMed
9. 9.↵
   1. Nanke Y,
   2. Kotake S,
   3. Akama H,
   4. et al

   . Alkaline phosphatase in rheumatoid arthritis patients: possible contribution of bone-type ALP to the raised activities of ALP in rheumatoid arthritis patients. Clin Rheumatol 2002;21:198–202

   CrossRefPubMed
10. 10.↵
    Kidney Disease Outcome Quality Initiative: Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification. National Kidney Foundation. Published January 2002. Updated April 19, 2003. http://www.kidney.org/professionals/kdoqi/guidelines_ckd/toc.htm. Accessed July 14, 2013
11. 11.↵
    1. Goldacre MJ,
    2. Wotton CJ,
    3. Keenan TD

    . Risk of selected eye diseases in people admitted to hospital for hypertension or diabetes mellitus: record linkage studies. Br J Ophthalmol 2012;96:872–76

    Abstract/FREE Full Text
12. 12.↵
    1. Jeganathan VS,
    2. Wang JJ,
    3. Wong TY

    . Ocular associations of diabetes other than diabetic retinopathy. Diabetes Care 2008;31:1905–12

    FREE Full Text
13. 13.↵
    1. Okada J,
    2. Nomura M,
    3. Shirataka M,
    4. et al

    . Prevalence of soft tissue calcifications in patients with SLE and effects of alfacarcidol. Lupus 1999;8:456–61

    Abstract/FREE Full Text
14. 14.↵
    1. Fairweather D,
    2. Frisancho-Kiss S,
    3. Rose N

    . Sex differences in autoimmune disease from a pathological perspective. Am J Pathol 2008;173:600–09

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Shantsila E,
    2. Lip GY

    . Systemic inflammation as a driver of vascular calcification: a proof of concept. J Intern Med 2009;266:453–56

    CrossRefPubMed
16. 16.↵
    1. Masuda Y,
    2. Uchiyama Y,
    3. Hashimoto S,
    4. et al

    . Symmetrica l progressive intracranial calcification in a patient with SLE. Intern Med 2010;49:351

    CrossRefPubMed
17. 17.↵
    1. Yiu KH,
    2. Mok MY,
    3. Wang S,
    4. et al

    . Prognostic role of coronary calcification in patients with rheumatoid arthritis and systemic lupus erythematosus. Clin Exp Rheumatol 2012;30:345–50

    PubMed
18. 18.↵
    1. Plazak W,
    2. Pasowicz M,
    3. Kostkiewicz M,
    4. et al

    . Influence of chronic inflammation and autoimmunity on coronary calcifications and myocardial perfusion defects in systemic lupus erythematosus patients. Inflamm Res 2011;60:973–80

    CrossRefPubMed
19. 19.↵
    1. Paccou J,
    2. Brazier M,
    3. Mentaverri R,
    4. et al

    . Vascular calcification in rheumatoid arthritis: prevalence, pathophysiological aspects and potential targets. Atherosclerosis 2012;224:283–90

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Llamas-Velasco M,
    2. Eguren C,
    3. Santiago D,
    4. et al

    . Calcinosis cutis and Sjögren's syndrome. Lupus 2010;19:762–64

    Abstract/FREE Full Text
21. 21.↵
    1. Ortiz A,
    2. Ceccato F,
    3. Roverano S,
    4. et al

    . Calciphylaxis associated with rheumatoid arthritis: communication of the second case. Clin Rheumatol 2009;28(suppl 1):S65–68

    PubMed
22. 22.↵
    1. Igaki N,
    2. Moriguchi R,
    3. Hirota Y,
    4. et al

    . Calciphylaxis in a patient with end-stage renal disease secondary to systemic lupus erythematosus associated with acral gangrene and mesenteric ischemia. Intern Med 2001;40:1232–37

    CrossRefPubMed
23. 23.↵
    1. Sugimoto H,
    2. Hyodoh K,
    3. Kikuno M,
    4. et al

    . Periarticular calcification in systemic lupus erythematosus. J Rheumatol 1999;26:574–79

    PubMedWeb of Science
24. 24.↵
    1. MacLean C,
    2. Brahn E

    . Systemic lupus erythematosus: calciphylaxis induced cardiomyopathy. J Rheumatol 1995;22:177–79

    PubMedWeb of Science
25. 25.↵
    1. Minami A,
    2. Suda K,
    3. Kaneda K,
    4. et al

    . Extensive subcutaneous calcification of the forearm in systemic lupus erythematosus. J Hand Surg Br 1994;19:638–41

    Abstract/FREE Full Text
26. 26.↵
    1. Mandelbrot DA,
    2. Santos PW,
    3. Burt RK,
    4. et al

    . Resolution of SLE-related soft-tissue calcification following haematopoietic stem cell transplantation. Nephrol Dial Transplant 2008;23:2679–84

    Abstract/FREE Full Text
27. 27.↵
    1. Tristano AG,
    2. Villarroel JL,
    3. Rodríguez MA,
    4. et al

    . Calcinosis cutis universalis in a patient with systemic lupus erythematosus. Clin Rheumatol 2006;25:70–74

    CrossRefPubMed
28. 28.↵
    1. Lee S,
    2. Joo KB,
    3. Lee KH,
    4. et al

    . Acute retropharyngeal calcific tendinitis in an unusual location: a case report in a patient with rheumatoid arthritis and atlantoaxial subluxation. Korean J Radiol 2011;12:504–09

    CrossRefPubMed
29. 29.↵
    1. Kapustin AN,
    2. Davies JD,
    3. Reynolds JL,
    4. et al

    . Calcium regulates key components of vascular smooth muscle cell-derived matrix vesicles to enhance mineralization. Circ Res 2011;109:e1–12

    Abstract/FREE Full Text
30. 30.↵
    1. Osorio A,
    2. Ortega E,
    3. Torres JM,
    4. et al

    . Biochemical markers of vascular calcification in elderly hemodialysis patients. Mol Cell Biochem 2013;374:212–17
31. 31.↵
    1. Shroff RC,
    2. McNair R,
    3. Skepper JN,
    4. et al

    . Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification. J Am Soc Nephrol 2010;21:103–12

    Abstract/FREE Full Text
32. 32.↵
    1. Jensen T,
    2. Hansen M,
    3. Madsen JC,
    4. et al

    . Serum levels of parathyroid hormone and markers of bone metabolism in patients with rheumatoid arthritis. Relationship to disease activity and glucocorticoid treatment. Scand J Clin Lab Invest 2001;61:491–501

    CrossRefPubMed
33. 33.↵
    1. Korczowska I,
    2. Łacki JK,
    3. Leszczyński P,
    4. et al

    . Bone tissue metabolism in systematic lupus erythematosus patients treated with glucocorticosteroids [in Polish]. Pol Arch Med Wewn 2001;106:901–07

    PubMed